Trial NCT01274221

View at ClinicalTrials.gov 
Org. Study IDs: SPD489-321

Last trial update was posted on 2021-06-03

MeSH Interventions

Lisdexamfetamine Dimesylate

MeSH Conditions

Attention Deficit Disorder with Hyperactivity

Other Conditions

ADHD

Stopping Reasons

Cancellation was not safety related but a shift in study priorities for Shire.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID